Cimzia Versus Cimzia Plus Azathioprine in the Treatment of Active Crohn's Disease
Status:
Unknown status
Trial end date:
2014-11-01
Target enrollment:
Participant gender:
Summary
This is a randomized, double blind trial of combination therapy (Cimzia plus Azathioprine)
versus mono therapy (Cimzia alone) and the improvement in mean SES-CD (Simple Endoscopic
Scoring in Crohn's Disease) score.
It is a trial where the investigators are administering biological therapy by itself and
biological therapy plus an immunosuppressive medicine in combination to see which form of
therapy has a better effect on healing ulcerations in the small intestine and colon that are
due to a flare up of Crohn's disease.